246 related articles for article (PubMed ID: 10978061)
1. Tirilazad mesylate in acute ischemic stroke: A systematic review. Tirilazad International Steering Committee.
Stroke; 2000 Sep; 31(9):2257-65. PubMed ID: 10978061
[TBL] [Abstract][Full Text] [Related]
2. Tirilazad for acute ischaemic stroke.
Bath PM; Iddenden R; Bath FJ; Orgogozo JM;
Cochrane Database Syst Rev; 2001; (4):CD002087. PubMed ID: 11687138
[TBL] [Abstract][Full Text] [Related]
3. Tirilazad for aneurysmal subarachnoid haemorrhage.
Zhang S; Wang L; Liu M; Wu B
Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators.
Stroke; 1996 Sep; 27(9):1453-8. PubMed ID: 8784112
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
[TBL] [Abstract][Full Text] [Related]
7. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.
Jang YG; Ilodigwe D; Macdonald RL
Neurocrit Care; 2009; 10(1):141-7. PubMed ID: 18810661
[TBL] [Abstract][Full Text] [Related]
8. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury.
Marshall LF; Maas AI; Marshall SB; Bricolo A; Fearnside M; Iannotti F; Klauber MR; Lagarrigue J; Lobato R; Persson L; Pickard JD; Piek J; Servadei F; Wellis GN; Morris GF; Means ED; Musch B
J Neurosurg; 1998 Oct; 89(4):519-25. PubMed ID: 9761043
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
Lanzino G; Kassell NF
J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246
[TBL] [Abstract][Full Text] [Related]
10. Aminosteroids for acute traumatic brain injury.
Roberts I
Cochrane Database Syst Rev; 2000; 1999(4):CD001527. PubMed ID: 11034722
[TBL] [Abstract][Full Text] [Related]
11. Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS).
STIPAS Investigators
Stroke; 1994 Feb; 25(2):418-23. PubMed ID: 8303754
[TBL] [Abstract][Full Text] [Related]
12. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators.
Johnston KC; Li JY; Lyden PD; Hanson SK; Feasby TE; Adams RJ; Faught RE; Haley EC
Stroke; 1998 Feb; 29(2):447-53. PubMed ID: 9472888
[TBL] [Abstract][Full Text] [Related]
13. The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke.
van der Worp HB; Kappelle LJ; Algra A; Bär PR; Orgogozo JM; Ringelstein EB; Bath PM; van Gijn J; ;
Neurology; 2002 Jan; 58(1):133-5. PubMed ID: 11781420
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke.
Sena E; Wheble P; Sandercock P; Macleod M
Stroke; 2007 Feb; 38(2):388-94. PubMed ID: 17204689
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
Kassell NF; Haley EC; Apperson-Hansen C; Alves WM
J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224
[TBL] [Abstract][Full Text] [Related]
16. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators.
Saver JL; Johnston KC; Homer D; Wityk R; Koroshetz W; Truskowski LL; Haley EC
Stroke; 1999 Feb; 30(2):293-8. PubMed ID: 9933262
[TBL] [Abstract][Full Text] [Related]
17. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.
Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289
[TBL] [Abstract][Full Text] [Related]
18. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.
Dávalos A; Castillo J; Alvarez-Sabín J; Secades JJ; Mercadal J; López S; Cobo E; Warach S; Sherman D; Clark WM; Lozano R
Stroke; 2002 Dec; 33(12):2850-7. PubMed ID: 12468781
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials.
Bath PM; Iddenden R; Bath FJ
Stroke; 2000 Jul; 31(7):1770-8. PubMed ID: 10884486
[TBL] [Abstract][Full Text] [Related]
20. [Indications for steroid and tirilazad treatment in patients with subarachnoid hemorrhage].
Tommasino C; Picozzi P
Minerva Anestesiol; 1998 May; 64(5):225-7. PubMed ID: 9773664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
